1 |
Andrews RH, Sithithaworn P, Petney TN (2008). Opisthorchis viverrini: an underestimated parasite in the world. Trends in Parasitology, 24, 497-501.
DOI
ScienceOn
|
2 |
Boonmars T, Srisawangwong T, Srirach P, et al (2007). Apoptosis- related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. Parasitol Res, 102, 57-62.
DOI
|
3 |
Bureau of Epidemiology, Ministry of Public Health of Thailand (2008). Annual Epidemiological Surveillance Report, 122-3.
|
4 |
Bureau of Epidemiology, Ministry of Public Health, Thailand (2009). Annual Epidemiological Surveillance Report, 128-9.
|
5 |
Jongsuksuntigul P, Imsomboon T (1997). The impact of a decade long opisthorchiasis control program in northeastern, Thailand. Southeast Asian J Trop Med Public Health, 28, 551-7.
|
6 |
Kaewpitoon N, Kaewpitoon SJ, Pengsaa P (2008). Opisthorchaisis in Thailand: Review and current status. World J Gastroenterol, 14, 2297-302.
DOI
ScienceOn
|
7 |
Kamsa-ard S, Wiangnon S, Suwanrungruang K, et al (2011). Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: Cholangiocarcinoma. Asian Pac J Cancer Prev, 12, 2209-13.
|
8 |
Khuhaprema T, Srivatanakul P (2006). Cancer in Thailand. National Cancer Institute, 4, 37.
|
9 |
Lovis L, Mak TK, Phongluxa K, et al (2012). Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS Negl Trop Dis, 6, 1726.
DOI
|
10 |
Melman SD, Steinauer ML, Cunningham C, et al (2009). Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis, 3, 504.
DOI
ScienceOn
|
11 |
Nithikathkul C, Wichmann O, Polseela P, et al (2004). Health behavior associated with Opisthorchis viverrini infection in Khukan district, Si Sa Ket Province, Thailand. Southeast Asian J Trop Med Public Health, 35, 309-12.
|
12 |
Poomphakwaen K, Promthet S, Kamsa-ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev, 10, 251-7.
|
13 |
Prasongwatana J, Laummaunwai P, Boonmars T, Pinlaor S (2012). Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes-as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol Res, 10, 3154-9.
|
14 |
Pungpak S, Bunnag D, Harinasuta T (1985). Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. Southeast Asian J Trop Med Public Hlth, 16, 248-52.
|
15 |
Pungpak S, Radomyos P, Radomyos B, et al (1998). Treatment of Opisthorchiasis viverrini and intestinal fluke infections with praziquantel. Southeast Asian J Trop Med Public Hlth, 29, 246-9
|
16 |
Rangsin R, Mungthin M, Taamasri P, et al (2009). Incidence and risk factors of Opisthorchis viverrini infections in a rural community in Thailand. Am J Trop Med Hyg, 81, 152-5.
|
17 |
Rhongbutsri P, Kitvatanachai S (2002). Survey of the fluke infection rate in Ban Khok Yai village, Khon Kaen, Thailand. J Trop Med Parasitol, 25, 76-8.
|
18 |
Saengsawang P, Promthet S, Bradshaw P (2012). Prevalence of OV infection in Yasothon Province, Northeast Thailand. Asian Pacific J Cancer Prev, 13, 3399-402.
DOI
ScienceOn
|
19 |
Sithithaworn P, Andrews RH, Van De N, et al (2012). The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitology Int, 61, 10-6.
DOI
ScienceOn
|
20 |
Sithithaworn P, Haswell–Elkins M (2003).Epidemiology of Opisthorchis viverrini. ActaTropica, 88, 187-94.
|
21 |
Sirisinha, S, Tuti S, Tawatsin A, et al (1983). Attempts to induce protective immunity in hamsters against infection by a liver fluke of man (Opisthorchis viverrini). Parasitology, 86, 127-36.
DOI
|
22 |
Soukhathammavong P, Odermatt P, Sayasone S, et al (2011). Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, openlabel, phase 2 trial. Lancet Infect Dis, 11, 110-18.
DOI
ScienceOn
|
23 |
Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201.
DOI
|
24 |
Sripa B, Brindley PJ, Mulvenna J, et al (2012). The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends in Parasitol, 28, 395-407.
DOI
ScienceOn
|
25 |
Supanvanich S, Supanvanich K, Pawabut P (1981). Field trial of praziquantel in human opisthorchiasis in Thailand. Southeast Asian J Trop Med Public Health, 12, 598-602.
|
26 |
Upatham ES, Viyanant V, Brockelman WY, et al (1988). Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol, 18, 643-9.
DOI
ScienceOn
|
27 |
Upatham ES, Viyanant V, Kurathong S et al (1984). Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in northeast Thailand. Bull World Health Organ, 62, 451-61.
|
28 |
Watanapa P, Watanapa WB (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
DOI
ScienceOn
|
29 |
World Health Organisation (1991). Basic laboratory methods in medical parasitology. World Health Organisation, Geneva.
|
30 |
World Health Organisation (2003). Adherence to long-term therapies: evidence for action. World Health Organisation, Geneva.
|